Canada Creating Genomics Innovation Network
News Jun 04, 2014
Genome Canada have released a request for applications for membership in the Genomics Innovation Network (GIN) and core operations support funds.
“The goal of this network will be to facilitate an environment that allows innovation centres across Canada to collaborate and harness their collective power for the advancement of genomics research,” said Dr. Pierre Meulien, Genome Canada’s President and CEO.
The vision is for each network member, to be designated as a Node, to provide researchers access to high throughput genomic technologies, such as DNA sequencing, RNA expression, protein identification and quantitation, and metabolomics, as well as new method and protocol development, data analysis and bioinformatics. Nodes will also assist researchers in the development of research proposals by providing advice on appropriate technologies, study design, data analysis and bioinformatics that improve the quality of the research.
The competition will provide a total of up to $16 million to the successful applicants. This support is provided from the $165 million provided to Genome Canada from the Government of Canada in Budget 2013. Up to $2 million is available for each Node to support core operations, with a requirement that they secure an equal amount of co-funding from other partners. Facilities that are successful in applying for membership, and have been provided with core operating funds, can then apply for technology development funds that Genome Canada will supply through a subsequent competition to GIN members.
Applicants must register with their regional Genome Centre by August 1, 2014, with applications submitted September 15, 2014 and award notices issued in December 2014.
Genome Canada funds and manages large-scale, milestone-driven genomics research projects in the areas of agriculture, energy, environment, fisheries, forestry, health, and mining. Genome Canada’s mission includes a commitment to provide researchers across Canada access to leading-edge technology in all genomics-related fields.
“Canada is a global leader in genomics, and the Genomics Innovation Network will ensure Canadians reap the full benefit of our investments. This is about ensuring that the latest developments in this fast moving field will rapidly make their way into society, whether by improving the health of Canadians, creating new companies in advanced manufacturing, or protecting our vast natural resources through responsible and efficient extraction and remediation technologies,” said Dr. Meulien.
Neural Computer Hears Like HumansNews
Modelling the human senses is an incredibly complex task. Our brains arrange cells into complex hierarchies that process information from our surroundings. Now, a group at MIT have created a model of the human auditory cortex that can hear sounds and music in the same way that humans do.READ MORE
Stable Beta-Amyloid Dimers Identified in Alzheimer’s BrainsNews
A recent study exploited state-of-the-art mass spectrometry to provide the first direct evidence of beta-amyloid dimers in patients with Alzheimer’s disease and points to the potential of these molecules as biomarkers. Beta-amyloid dimers may be the smallest pathological species that trigger Alzheimer’s disease.
Comments | 0 ADD COMMENT
2nd International Conference and Exhibition on Nanomedicine and Drug Delivery
May 21 - May 23, 2018